Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E Nelson

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Emergency Medicine Clinics of North America|November 27, 2013
Emerging drugs of abuseMichael E Nelson, Sean M Bryant, Steven E Aks
Clinical Toxicology (Philadelphia, Pa.)|November 6, 2012
Melanotan II injection resulting in systemic toxicity and rhabdomyolysisMichael E Nelson, Sean M Bryant, Steven E Aks
Disease-A-Month : DM|March 18, 2014
Emerging drugs of abuseMichael E Nelson, Sean M Bryant, Steven E Aks
Journal of Medicinal Chemistry|July 9, 2004
2-amino-O4-benzylpteridine derivatives: potent inactivators of O6-alkylguanine-DNA alkyltransferaseMichael E Nelson, Natalia A Loktionova, Anthony E Pegg, et al.
Disease-A-Month : DM|March 12, 2016
Atlas of select poisonous plants and mushroomsChristopher S Lim, Neeraj Chhabra, Scott Leikin, et al.
Plos Neglected Tropical Diseases|February 1, 2008
Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascadeAnton Simeonov, Ajit Jadhav, Ahmed A Sayed, et al.
Chest|February 9, 2012
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesClive Kearon, Elie A Akl, Anthony J Comerota, et al.
Journal of Medicinal Chemistry|March 13, 2008
Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamaseKerim Babaoglu, Anton Simeonov, John J Irwin, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Emergency Medicine Clinics of North America|November 27, 2013
Emerging drugs of abuseMichael E Nelson, Sean M Bryant, Steven E Aks
Clinical Toxicology (Philadelphia, Pa.)|November 6, 2012
Melanotan II injection resulting in systemic toxicity and rhabdomyolysisMichael E Nelson, Sean M Bryant, Steven E Aks
Disease-A-Month : DM|March 18, 2014
Emerging drugs of abuseMichael E Nelson, Sean M Bryant, Steven E Aks
Journal of Medicinal Chemistry|July 9, 2004
2-amino-O4-benzylpteridine derivatives: potent inactivators of O6-alkylguanine-DNA alkyltransferaseMichael E Nelson, Natalia A Loktionova, Anthony E Pegg, et al.
Disease-A-Month : DM|March 12, 2016
Atlas of select poisonous plants and mushroomsChristopher S Lim, Neeraj Chhabra, Scott Leikin, et al.
Plos Neglected Tropical Diseases|February 1, 2008
Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascadeAnton Simeonov, Ajit Jadhav, Ahmed A Sayed, et al.
Chest|February 9, 2012
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesClive Kearon, Elie A Akl, Anthony J Comerota, et al.
Journal of Medicinal Chemistry|March 13, 2008
Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamaseKerim Babaoglu, Anton Simeonov, John J Irwin, et al.
Pageof 2